GLP1R and polycystic ovary syndrome: Future research endeavors should focus on conducting larger, placebo-controlled trials to establish the efficacy and safety of GLP-1 RAs in PCOS populations. Longitudinal studies are needed to assess the durability of weight loss and metabolic improvements associated with GLP-1 therapy, as well as their impact on cardiovascular outcomes in the long term.